1.17
-0.01(-0.85%)
Currency In USD
| Previous Close | 1.18 |
| Open | 1.14 |
| Day High | 1.19 |
| Day Low | 1.11 |
| 52-Week High | 3.2 |
| 52-Week Low | 0.87 |
| Volume | 68,782 |
| Average Volume | 102,562 |
| Market Cap | 46.35M |
| PE | -1.1 |
| EPS | -1.06 |
| Moving Average 50 Days | 1.5 |
| Moving Average 200 Days | 1.71 |
| Change | -0.01 |
If you invested $1000 in TELA Bio, Inc. (TELA) since IPO date, it would be worth $87.64 as of November 08, 2025 at a share price of $1.17. Whereas If you bought $1000 worth of TELA Bio, Inc. (TELA) shares 5 years ago, it would be worth $69.56 as of November 08, 2025 at a share price of $1.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TELA Bio to Announce Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Nov 04, 2025 1:30 PM GMT
MALVERN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will re
TELA Bio Appoints William Plovanic to Board of Directors
GlobeNewswire Inc.
Nov 03, 2025 9:05 PM GMT
MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction s
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
GlobeNewswire Inc.
Oct 09, 2025 8:05 PM GMT
MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Betty